Savara Share Price Today
(NASDAQ: SVRA)

Name: Savara Share Price Today (NASDAQ: SVRA) - Savara Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Savara share price is $2.6 & ₹226.12 as on 6 Mar 2025, 2.30 'hrs' IST

$2.6

▲

0.21

(8.79%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Savara share price in Dollar and Rupees. Guide to invest in Savara stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Savara, along with analyst recommendations, forecasts, and comprehensive financials.

Savara share price movements

Today's Low: $2.46
Today's High: $2.60
$2.60
5.58%
Downside
Day's Volatility :5.58%
Upside
0.0%
52 Weeks Low: $2.31
52 Weeks High: $5.70
$2.60
11.15%
Downside
52 Weeks Volatility :59.47%
Upside
54.39%

Savara (SVRA) Returns

Period	Savara Inc	Index (Russel 2000)
3 Months	-33.61%	0.0%
6 Months	-47.36%	0.0%
1 Year	-55.9%	0.0%
3 Years	58.28%	-11.6%

Savara (SVRA) Key Statistics

in dollars & INR

Previous Close	$2.39
Open	$2.41
Today's High	$2.6
Today's Low	$2.455
Market Capitalization	$398.2M
Today's Volume	$262.7K
52 Week High	$5.7
52 Week Low	$2.31
Revenue TTM	$1000.0
EBITDA	$-88.7M
Earnings Per Share (EPS)	$-0.43
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-47.96%

How to invest in Savara Stock (SVRA) from India?

It is very easy for Indian residents to invest directly in Savara from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Savara stock in both Indian Rupees (INR) and US Dollars (USD). Search for Savara or SVRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Savara or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Savara shares which would translate to 0.334 fractional shares of Savara as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Savara, in just a few clicks!

Returns in Savara (SVRA) for Indian investors in Rupees

The Savara stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Savara investment value today

Current value as on today

₹52,933

Returns

₹47,067

(-47.07%)

Returns from Savara Stock

₹52,030 (-52.03%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Savara (SVRA)

-6%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Savara Stock from India on INDmoney has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Savara

NEA Management Company, LLC
14.26%
Bain Capital Life Sciences Investors, LLC
8.49%
TCG Crossover Management, LLC
7.20%
Vestal Point Capital LP
6.28%
BlackRock Inc
5.59%
Vanguard Group Inc
4.84%

Analyst Recommendation on Savara

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Savara(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Savara Stock (SVRA)

What analysts predicted

Upside of 232.42%

Target:

$8.64

Current:

$2.60

Insights on Savara Stock (Ticker Symbol: SVRA)

Price Movement
In the last 6 months, SVRA stock has moved down by -47.4%
SVRA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 118.3%

Savara Technicals Summary

Sell

Neutral

Buy

Savara is currently in a neutral trading position according to technical analysis indicators.

Savara (SVRA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Savara Inc	-14.64%	-47.36%	-55.9%	58.28%	58.28%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Savara Inc	NA	NA	0.0	-0.48	-0.48	-0.26	NA	0.95
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Savara Inc	Buy	$398.2M	58.28%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Savara

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.

Organization	Savara
Employees	37
CEO	Mr. Matthew Pauls J.D., M.B.A.
Industry	Health Technology

Management People of Savara

Name	Title
Mr. Matthew Pauls J.D., M.B.A.	Chairman & CEO
Mr. David L. Lowrance CPA	CFO, Chief Administrative Officer & Secretary
Mr. Robert Matthew Lutz M.B.A.	Chief Operating Officer
Ms. Kate McCabe J.D.	Senior VP & General Counsel
Ms. Anne Erickson	Chief Business Officer
Brian Maurer	Head of Clinical Operations
Mr. Charles LaPree	Senior Vice President of Global Regulatory Affairs & Quality Assurance
Dr. Peter Clarke Ph.D.	Executive Vice President of Global Technical Operations
Dr. Raymond Dennis Pratt FACP, M.D.	Chief Medical Officer
Mr. Scott L. Wilhoit	Executive Vice President of Global Commercial

Important FAQs about investing in SVRA Stock from India :

What is Savara share price today?

Savara share price today stands at $2.60, Open: $2.41 ; Previous Close: $2.39 ; High: $2.60 ; Low: $2.46 ; 52 Week High: $5.70 ; 52 Week Low: $2.31.

The stock opens at $2.41, after a previous close of $2.39. The stock reached a daily high of $2.60 and a low of $2.46, with a 52-week high of $5.70 and a 52-week low of $2.31.

Can Indians buy Savara shares?

Yes, Indians can invest in the Savara (SVRA) from India.

With INDmoney, you can buy Savara at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Savara at zero transaction cost.

How can I buy Savara shares from India?

It is very easy to buy Savara from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Savara (SVRA) be purchased?

Yes, you can buy fractional shares of Savara with INDmoney app.

What are the documents required to start investing in Savara stocks?

To start investing in Savara, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.